Director of R&D: Rare Disease Late-Stage Programs

Cycle Pharmaceuticals in Cambridge is seeking an accomplished Director of Research & Development to own the late-stage development and delivery of programmes targeting rare metabolic and genetic diseases. This hybrid role reports to the Chief Strategy Officer and requires minimum 3 days in the office.

You will define development strategy, drive execution through regulatory submission, and support FDA interactions, while mentoring an integrated R&D function spanning Product Development, Clinical